» Articles » PMID: 16081983

Decreased Prevalence of Virulence Factors Among Ciprofloxacin-resistant Uropathogenic Escherichia Coli Isolates

Overview
Specialty Microbiology
Date 2005 Aug 6
PMID 16081983
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Ciprofloxacin resistance was identified in 18% and 6% of consecutively collected, clinically significant urinary tract isolates of Escherichia coli from inpatients and outpatients, respectively. In comparison to ciprofloxacin-susceptible isolates, there were fewer resistant isolates that expressed beta-hemolysis (outpatient, 9% versus 87%, P < 0.0001; inpatient, 4% versus 76%, P < 0.0001) and that had a papEF genotype, genes encoding P fimbriae (outpatient, 30% versus 70%, P = 0.0004; inpatient, 26% versus 70%, P < 0.0001).

Citing Articles

Risk Factors for Recurrence of Community-Onset Urinary Tract Infections Caused by Extended-Spectrum Cephalosporin-Resistant Enterobacterales.

Zhang H, Perez R, Krishnan J, Lautenbach E, Anderson D Open Forum Infect Dis. 2023; 10(12):ofad561.

PMID: 38130594 PMC: 10733196. DOI: 10.1093/ofid/ofad561.


Metabolic and Morphotypic Trade-Offs within the Eco-Evolutionary Dynamics of Escherichia coli.

Zlatkov N, Nasman M, Uhlin B Microbiol Spectr. 2022; 10(5):e0067822.

PMID: 36169422 PMC: 9602443. DOI: 10.1128/spectrum.00678-22.


In Vitro Reduction of Interleukin-8 Response to by Strains Isolated from the Same Polymicrobial Urines.

Piatti G, De Ferrari L, Schito A, Riccio A, Penco S, Cassia S Microorganisms. 2021; 9(7).

PMID: 34361936 PMC: 8307267. DOI: 10.3390/microorganisms9071501.


Poultry hatcheries as potential reservoirs for antimicrobial-resistant Escherichia coli: A risk to public health and food safety.

Osman K, Kappell A, Elhadidy M, Elmougy F, Abd El-Ghany W, Orabi A Sci Rep. 2018; 8(1):5859.

PMID: 29643424 PMC: 5895583. DOI: 10.1038/s41598-018-23962-7.


A study on the aac-(6)-lb-cr gene prevalence among ciprofloxacin-resistant strains of uropathogenic .

Soundararajan N, Shanmugam P, Devanbu C, Sattar S Int J Appl Basic Med Res. 2016; 6(4):258-261.

PMID: 27857893 PMC: 5108102. DOI: 10.4103/2229-516X.192603.


References
1.
Wullt B, Bergsten G, Connell H, Rollano P, Gebratsedik N, Hang L . P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell Microbiol. 2001; 3(4):255-64. DOI: 10.1046/j.1462-5822.2001.00111.x. View

2.
Naber K . Which fluoroquinolones are suitable for the treatment of urinary tract infections?. Int J Antimicrob Agents. 2001; 17(4):331-41. DOI: 10.1016/s0924-8579(00)00362-9. View

3.
Gillespie S, Voelker L, Dickens A . Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae. Microb Drug Resist. 2002; 8(2):79-84. DOI: 10.1089/107662902760190617. View

4.
Vila J, Simon K, Ruiz J, Horcajada J, Velasco M, Barranco M . Are quinolone-resistant uropathogenic Escherichia coli less virulent?. J Infect Dis. 2002; 186(7):1039-42. DOI: 10.1086/342955. View

5.
Morin M, Hopkins W . Identification of virulence genes in uropathogenic Escherichia coli by multiplex polymerase chain reaction and their association with infectivity in mice. Urology. 2002; 60(3):537-41. DOI: 10.1016/s0090-4295(02)01766-1. View